These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2028443)

  • 1. Heparin cofactor II: experimental approach to a new assay and clinical results.
    Vinazzer H; Stocker K
    Thromb Res; 1991 Feb; 61(3):235-41. PubMed ID: 2028443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
    Abildgaard U; Larsen ML
    Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III.
    Kario K; Matsuo T; Kobayashi H
    Thromb Res; 1992 Jun; 66(5):489-98. PubMed ID: 1381849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB; Newton GR; Doctor VM
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects.
    Nakhleh R; Vogt JM; Edson JR
    Am J Clin Pathol; 1988 Mar; 89(3):353-8. PubMed ID: 3348170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of purified dermatan sulfate for heparin cofactor II (HC II) assay.
    Ruzzenente O; Ghidini R; Poli G; Schiavon R; Guidi GC
    Thromb Res; 1992 Jan; 65(2):281-7. PubMed ID: 1579900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
    Kaji T; Ejiri N; Hayakawa Y; Hayashi T; Sakuragawa N
    Thromb Res; 1990 Jul; 59(2):269-77. PubMed ID: 2122537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
    Carson L; Doctor VM
    Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin cofactor II: a simple assay method and results of its clinical application.
    Vinazzer H; Pangraz U
    Thromb Res; 1987 Oct; 48(2):153-60. PubMed ID: 3424287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The second cofactor of heparin].
    Sie P
    Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma.
    Dupouy D; Sié P; Dol F; Boneu B
    Thromb Haemost; 1988 Oct; 60(2):236-9. PubMed ID: 3217919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II.
    Yamagishi R; Koide T; Sakuragawa N
    FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
    Andersson TR; Sie P; Pelzer H; Aamodt LM; Nustad K; Abildgaard U
    Thromb Res; 1992 Jun; 66(5):591-8. PubMed ID: 1523613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.